Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 25:11:569524.
doi: 10.3389/fimmu.2020.569524. eCollection 2020.

The Long Non-coding RNAs: Paramount Regulators of the NLRP3 Inflammasome

Affiliations
Review

The Long Non-coding RNAs: Paramount Regulators of the NLRP3 Inflammasome

Mridula P Menon et al. Front Immunol. .

Abstract

The NOD LRR pyrin domain containing protein 3 (NLRP3) inflammasome is a cytosolic multi-proteins conglomerate with intrinsic ATPase activity. Their predominant presence in the immune cells emphasizes its significant role in immune response. The downstream effector proteins IL-1β and IL-18 are responsible for the biological functions of the NLRP3 inflammasome upon encountering the alarmins and microbial ligands. Although the NLRP3 inflammasome is essential for host defense during infections, uncontrolled activation and overproduction of IL-1β and IL-18 increase the risk of developing autoimmune and metabolic disorders. Emerging evidences suggest the action of lncRNAs in regulating the activity of NLRP3 inflammasome in various disease conditions. The long non-coding RNA (lncRNA) is an emerging field of study and evidence on their regulatory role in various diseases is grabbing attention. Recent studies emphasize the functions of lncRNAs in the fine control of the NLRP3 inflammasome at nuclear and cytoplasmic levels by interfering in chromatin architecture, gene transcription and translation. Recently, lncRNAs are also found to control the activity of various regulators of NLRP3 inflammasome. Understanding the precise role of lncRNA in controlling the activity of NLRP3 inflammasome helps us to design targeted therapies for multiple inflammatory diseases. The present review is a novel attempt to consolidate the substantial role of lncRNAs in the regulation of the NLRP3 inflammasome. A deeper insight on the NLRP3 inflammasome regulation by lncRNAs will help in developing targeted and beneficial therapeutics in the future.

Keywords: NLRP3 inflammasome; chromatin remodeling; cytoplasmic regulation; decoys; lncRNAs; nuclear regulation; scaffolds; transcriptional regulation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The NLRP3 inflammasome regulating lncRNAs in the activation and differentiation of myeloid and lymphoid cells.
Figure 2
Figure 2
The role of lncRNAs in the activation and repression of NLRP3 inflammasome in response to multiple stimuli.
Figure 3
Figure 3
Regulation of the NLRP3 inflammasome by lncRNAs at different cellular locations.
Figure 4
Figure 4
General ways involved in regulating the NLRP3 inflammasome by lncRNAs.

Similar articles

Cited by

References

    1. Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. (2019) 20:3328. 10.3390/ijms20133328 - DOI - PMC - PubMed
    1. Swanson KV, Deng M, Ting JPY. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. (2019) 33:477–89. 10.1038/s41577-019-0165-0 - DOI - PMC - PubMed
    1. Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. (2019) 10:1–1. 10.1038/s41419-019-1413-8 - DOI - PMC - PubMed
    1. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. (2005) 73:1907–16. 10.1128/IAI.73.4.1907-1916.2005 - DOI - PMC - PubMed
    1. Menu P, Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol. (2011) 166:1–15. 10.1111/j.1365-2249.2011.04440.x - DOI - PMC - PubMed

Publication types